Î’3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
This study on biological samples of patients affected by neuroblastoma and Ewing sarcoma aims at validating the beta3-adrenoreceptor as prognostic biomarker.
Neuroblastoma|Ewing Sarcoma
DIAGNOSTIC_TEST: beta3 expression
expression of beta3-adrenoreceptor, from enrollment to the performance of the analysis that can take up to 6 weeks
This study on biological samples of patients affected by neuroblastoma and Ewing sarcoma aims at validating the beta3-adrenoreceptor as prognostic biomarker.